Cyclophosphamide/Fludarabine (CF) is Active in the Treatment of Mantle Cell Lymphoma
Bradley J. Cohen(Memorial Sloan Kettering Cancer Center), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Ariela Noy, Eric Hedrick(Biogen (United States)), Craig Moskowitz(Memorial Sloan Kettering Cancer Center), David Straus(Memorial Sloan Kettering Cancer Center)
Cited by 76
Related Papers
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
|Journal of Clinical Oncology|2012|1.1k